| NDC包装代码 | 产品NDC | 产品类型 | 商品名 | 通用名 | 剂型 | 给药途径 | 上市日期 | 结束日期 | 市场类别 | 申请号 | 标签持有者 | 活性成分 | 规格 | 包装描述 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 60215-411-15 | 60215-411 | HUMAN PRESCRIPTION DRUG | Fludeoxyglucose F18 | Fludeoxyglucose F18 | INJECTION | INTRAVENOUS | 20111206 | N/A | ANDA | ANDA203246 | The University of Texas MD Anderson Cancer Center | FLUDEOXYGLUCOSE F-18 | 300 mCi/mL | 15 mL in 1 VIAL, GLASS (60215-411-15) |
| 60215-411-30 | 60215-411 | HUMAN PRESCRIPTION DRUG | Fludeoxyglucose F18 | Fludeoxyglucose F18 | INJECTION | INTRAVENOUS | 20111206 | N/A | ANDA | ANDA203246 | The University of Texas MD Anderson Cancer Center | FLUDEOXYGLUCOSE F-18 | 300 mCi/mL | 27 mL in 1 VIAL, GLASS (60215-411-30) |